back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2024-04-25 14:03 Tx date 2024-04-12 |
$GUD
Knight Therapeutics Inc. |
Utchanah, Arvind
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$715,000
+125,000 vol $5.72 each |
725,203 | |
| Filed 2024-04-25 14:03 Tx date 2024-04-12 |
$GUD
Knight Therapeutics Inc. |
Utchanah, Arvind
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$715,000
+125,000 vol $5.72 each |
600,203 | |
| Filed 2024-04-25 14:02 Tx date 2024-04-12 |
$GUD
Knight Therapeutics Inc. |
Utchanah, Arvind
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$901,809
+157,659 vol $5.72 each |
475,203 | |
| Filed 2024-04-16 18:13 Tx date 2024-04-12 |
$GUD
Knight Therapeutics Inc. |
Utchanah, Arvind
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$712,500
+125,000 vol $5.70 each |
||
| Filed 2024-04-16 18:13 Tx date 2024-04-12 |
$GUD
Knight Therapeutics Inc. |
Utchanah, Arvind
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$712,500
+125,000 vol $5.70 each |
||
| Filed 2024-04-16 18:12 Tx date 2024-04-12 |
$GUD
Knight Therapeutics Inc. |
Utchanah, Arvind
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$894,854
+156,992 vol $5.70 each |
||
| Filed 2024-04-16 18:16 Tx date 2024-04-12 |
$GUD
Knight Therapeutics Inc. |
Utchanah, Arvind
5 - Senior Officer of Issuer
Direct Ownership
|
Performance stock Unit
56 - Grant of rights
|
$308,626
+54,145 vol $5.70 each |
95,923 | |
| Filed 2024-04-16 18:13 Tx date 2024-04-12 |
$GUD
Knight Therapeutics Inc. |
Utchanah, Arvind
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$712,500
+125,000 vol $5.70 each |
724,536 | |
| Filed 2024-04-16 18:13 Tx date 2024-04-12 |
$GUD
Knight Therapeutics Inc. |
Utchanah, Arvind
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$712,500
+125,000 vol $5.70 each |
599,536 | |
| Filed 2024-04-16 18:12 Tx date 2024-04-12 |
$GUD
Knight Therapeutics Inc. |
Utchanah, Arvind
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$894,854
+156,992 vol $5.70 each |
474,536 | |
| Filed 2024-04-05 16:14 Tx date 2024-04-01 |
$GUD
Knight Therapeutics Inc. |
Utchanah, Arvind
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$88,303
+16,661 vol $5.30 each |
39,136 | |
| Filed 2024-04-05 16:13 Tx date 2024-04-01 |
$GUD
Knight Therapeutics Inc. |
Utchanah, Arvind
5 - Senior Officer of Issuer
Direct Ownership
|
Performance stock Unit
57 - Exercise of rights
|
$-81,252.65
-14,381 vol $5.65 each |
41,778 | |
| Filed 2024-04-05 16:12 Tx date 2024-04-01 |
$GUD
Knight Therapeutics Inc. |
Utchanah, Arvind
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Unit
57 - Exercise of rights
|
$-40,623.50
-7,190 vol $5.65 each |
20,889 | |
| Filed 2024-03-19 20:12 Tx date 2024-03-15 |
$GUD
Knight Therapeutics Inc. |
Utchanah, Arvind
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$7,017
+1,324 vol $5.30 each |
22,475 | |
| Filed 2023-12-19 10:32 Tx date 2023-12-15 |
$GUD
Knight Therapeutics Inc. |
Utchanah, Arvind
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$6,047
+1,163 vol $5.20 each |
21,151 | |
| Filed 2023-09-19 11:22 Tx date 2023-09-15 |
$GUD
Knight Therapeutics Inc. |
Utchanah, Arvind
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$6,046
+1,368 vol $4.42 each |
19,988 | |
| Filed 2023-06-19 13:32 Tx date 2023-06-15 |
$GUD
Knight Therapeutics Inc. |
Utchanah, Arvind
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$5,899
+1,199 vol $4.92 each |
18,620 | |
| Filed 2023-04-02 23:58 Tx date 2023-03-30 |
$GUD
Knight Therapeutics Inc. |
Utchanah, Arvind
5 - Senior Officer of Issuer
Direct Ownership
|
Performance stock Unit
56 - Grant of rights
|
$103,469
+23,304 vol $4.44 each |
56,159 | |
| Filed 2023-04-02 23:57 Tx date 2023-03-30 |
$GUD
Knight Therapeutics Inc. |
Utchanah, Arvind
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Unit
56 - Grant of rights
|
$51,734
+11,652 vol $4.44 each |
28,079 | |
| Filed 2023-04-02 23:55 Tx date 2023-03-30 |
$GUD
Knight Therapeutics Inc. |
Utchanah, Arvind
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$166,655
+37,535 vol $4.44 each |
317,544 | |
| Filed 2023-03-19 23:00 Tx date 2023-03-15 |
$GUD
Knight Therapeutics Inc. |
Utchanah, Arvind
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$5,523
+1,096 vol $5.04 each |
17,421 | |
| Filed 2022-12-23 15:49 Tx date 2022-12-19 |
$GUD
Knight Therapeutics Inc. |
Utchanah, Arvind
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$583.00
+110 vol $5.30 each |
16,325 | |
| Filed 2022-12-23 15:49 Tx date 2022-12-19 |
$GUD
Knight Therapeutics Inc. |
Utchanah, Arvind
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$3,207
+604 vol $5.31 each |
16,215 | |
| Filed 2022-10-07 11:20 Tx date 2022-09-15 |
$GUD
Knight Therapeutics Inc. |
Utchanah, Arvind
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$5,438
+966 vol $5.63 each |
15,611 | |
| Filed 2022-09-21 16:27 Tx date 2022-09-15 |
$GUD
Knight Therapeutics Inc. |
Utchanah, Arvind
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$8,326
+1,479 vol $5.63 each |
||
| Filed 2022-09-21 16:27 Tx date 2022-09-15 |
$GUD
Knight Therapeutics Inc. |
Utchanah, Arvind
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$8,326
+1,479 vol $5.63 each |
16,124 | |
| Filed 2022-08-16 16:09 Tx date 2021-05-18 |
$GUD
Knight Therapeutics Inc. |
Utchanah, Arvind
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+24,933 vol |
248,482 | |
| Filed 2021-12-10 14:09 Tx date 2021-05-18 |
$GUD
Knight Therapeutics Inc. |
Utchanah, Arvind
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+24,933 vol |
||
| Filed 2021-12-10 13:09 Tx date 2021-05-18 |
$GUD
Knight Therapeutics Inc. |
Utchanah, Arvind
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+24,933 vol |
||
| Filed 2021-05-20 12:44 Tx date 2021-05-18 |
$GUD
Knight Therapeutics Inc. |
Utchanah, Arvind
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+24,940 vol |
||
| Filed 2021-05-20 11:07 Tx date 2021-05-18 |
$GUD
Knight Therapeutics Inc. |
Utchanah, Arvind
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+24,940 vol |
||
| Filed 2022-06-17 21:29 Tx date 2022-06-15 |
$GUD
Knight Therapeutics Inc. |
Utchanah, Arvind
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$11,906
+2,281 vol $5.22 each |
14,645 | |
| Filed 2022-03-29 10:43 Tx date 2022-03-24 |
$GUD
Knight Therapeutics Inc. |
Utchanah, Arvind
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$164,255
+31,527 vol $5.21 each |
280,009 | |
| Filed 2022-03-29 10:30 Tx date 2022-03-24 |
$GUD
Knight Therapeutics Inc. |
Utchanah, Arvind
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Unit
56 - Grant of rights
|
$48,124
+9,237 vol $5.21 each |
16,427 | |
| Filed 2022-03-29 09:43 Tx date 2022-03-24 |
$GUD
Knight Therapeutics Inc. |
Utchanah, Arvind
5 - Senior Officer of Issuer
Direct Ownership
|
Performance stock Unit
56 - Grant of rights
|
$96,249
+18,474 vol $5.21 each |
32,855 | |
| Filed 2022-03-28 16:47 Tx date 2022-03-22 |
$GUD
Knight Therapeutics Inc. |
Utchanah, Arvind
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$7,736
+1,417 vol $5.46 each |
12,364 | |
| Filed 2021-12-17 18:23 Tx date 2021-12-15 |
$GUD
Knight Therapeutics Inc. |
Utchanah, Arvind
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$3,831
+734 vol $5.22 each |
10,947 | |
| Filed 2021-12-10 14:09 Tx date 2021-05-18 |
$GUD
Knight Therapeutics Inc. |
Utchanah, Arvind
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+24,933 vol |
248,482 | |
| Filed 2021-12-10 13:09 Tx date 2021-05-18 |
$GUD
Knight Therapeutics Inc. |
Utchanah, Arvind
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+24,933 vol |
248,482 | |
| Filed 2021-12-10 13:09 Tx date 2021-05-18 |
$GUD
Knight Therapeutics Inc. |
Utchanah, Arvind
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+24,933 vol |
||
| Filed 2021-05-20 12:44 Tx date 2021-05-18 |
$GUD
Knight Therapeutics Inc. |
Utchanah, Arvind
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+24,940 vol |
||
| Filed 2021-05-20 12:44 Tx date 2021-05-18 |
$GUD
Knight Therapeutics Inc. |
Utchanah, Arvind
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+24,940 vol |
||
| Filed 2021-05-20 11:07 Tx date 2021-05-18 |
$GUD
Knight Therapeutics Inc. |
Utchanah, Arvind
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+24,940 vol |
||
| Filed 2021-05-20 11:07 Tx date 2021-05-18 |
$GUD
Knight Therapeutics Inc. |
Utchanah, Arvind
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+24,940 vol |
||
| Filed 2021-09-21 16:46 Tx date 2021-09-21 |
$GUD
Knight Therapeutics Inc. |
Utchanah, Arvind
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,560
+300 vol $5.20 each |
10,213 | |
| Filed 2021-09-20 17:14 Tx date 2021-09-20 |
$GUD
Knight Therapeutics Inc. |
Utchanah, Arvind
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$3,120
+600 vol $5.20 each |
9,913 | |
| Filed 2021-09-17 17:44 Tx date 2021-09-15 |
$GUD
Knight Therapeutics Inc. |
Utchanah, Arvind
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$4,651
+876 vol $5.31 each |
9,313 | |
| Filed 2021-06-18 19:51 Tx date 2021-06-15 |
$GUD
Knight Therapeutics Inc. |
Utchanah, Arvind
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$3,857
+732 vol $5.27 each |
8,437 | |
| Filed 2021-05-24 15:30 Tx date 2021-05-18 |
$GUD
Knight Therapeutics Inc. |
Utchanah, Arvind
5 - Senior Officer of Issuer
Direct Ownership
|
Performance stock Unit
56 - Grant of rights
|
$81,252
+14,381 vol $5.65 each |
14,381 | |
| Filed 2021-05-24 15:29 Tx date 2021-05-18 |
$GUD
Knight Therapeutics Inc. |
Utchanah, Arvind
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Unit
56 - Grant of rights
|
$40,623
+7,190 vol $5.65 each |
7,190 | |
| Filed 2021-05-20 12:47 Tx date 2021-05-18 |
$GUD
Knight Therapeutics Inc. |
Utchanah, Arvind
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Unit
97 - Other
|
$40,623
+7,190 vol $5.65 each |
||
| Filed 2021-05-20 12:46 Tx date 2021-05-18 |
$GUD
Knight Therapeutics Inc. |
Utchanah, Arvind
5 - Senior Officer of Issuer
Direct Ownership
|
Performance stock Unit
97 - Other
|
$81,252
+14,381 vol $5.65 each |
||
| Filed 2021-05-20 11:12 Tx date 2021-05-18 |
$GUD
Knight Therapeutics Inc. |
Utchanah, Arvind
5 - Senior Officer of Issuer
Direct Ownership
|
Performance stock Unit
97 - Other
|
$81,252
+14,381 vol $5.65 each |
||
| Filed 2021-05-20 11:10 Tx date 2021-05-18 |
$GUD
Knight Therapeutics Inc. |
Utchanah, Arvind
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Unit
97 - Other
|
$40,623
+7,190 vol $5.65 each |
||
| Filed 2021-05-20 12:47 Tx date 2021-05-18 |
$GUD
Knight Therapeutics Inc. |
Utchanah, Arvind
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Unit
97 - Other
|
$40,623
+7,190 vol $5.65 each |
7,190 | |
| Filed 2021-05-20 12:46 Tx date 2019-08-07 |
$GUD
Knight Therapeutics Inc. |
Utchanah, Arvind
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Unit
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2021-05-20 12:46 Tx date 2021-05-18 |
$GUD
Knight Therapeutics Inc. |
Utchanah, Arvind
5 - Senior Officer of Issuer
Direct Ownership
|
Performance stock Unit
97 - Other
|
$81,252
+14,381 vol $5.65 each |
14,381 | |
| Filed 2021-05-20 12:45 Tx date 2019-08-07 |
$GUD
Knight Therapeutics Inc. |
Utchanah, Arvind
5 - Senior Officer of Issuer
Direct Ownership
|
Performance stock Unit
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2021-05-20 12:44 Tx date 2021-05-18 |
$GUD
Knight Therapeutics Inc. |
Utchanah, Arvind
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+24,940 vol |
248,489 | |
| Filed 2021-05-20 11:12 Tx date 2021-05-18 |
$GUD
Knight Therapeutics Inc. |
Utchanah, Arvind
5 - Senior Officer of Issuer
Direct Ownership
|
Performance stock Unit
97 - Other
|
$81,252
+14,381 vol $5.65 each |
||
| Filed 2021-05-20 11:12 Tx date 2021-05-18 |
$GUD
Knight Therapeutics Inc. |
Utchanah, Arvind
5 - Senior Officer of Issuer
Direct Ownership
|
Performance stock Unit
97 - Other
|
$81,252
+14,381 vol $5.65 each |
14,381 | |
| Filed 2021-05-20 11:11 Tx date 2019-08-07 |
$GUD
Knight Therapeutics Inc. |
Utchanah, Arvind
5 - Senior Officer of Issuer
Direct Ownership
|
Performance stock Unit
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2021-05-20 11:11 Tx date 2019-08-07 |
$GUD
Knight Therapeutics Inc. |
Utchanah, Arvind
5 - Senior Officer of Issuer
Direct Ownership
|
Performance stock Unit
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2021-05-20 11:10 Tx date 2021-05-18 |
$GUD
Knight Therapeutics Inc. |
Utchanah, Arvind
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Unit
97 - Other
|
$40,623
+7,190 vol $5.65 each |
||
| Filed 2021-05-20 11:10 Tx date 2021-05-18 |
$GUD
Knight Therapeutics Inc. |
Utchanah, Arvind
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Unit
97 - Other
|
$40,623
+7,190 vol $5.65 each |
7,190 | |
| Filed 2021-05-20 11:08 Tx date 2019-08-07 |
$GUD
Knight Therapeutics Inc. |
Utchanah, Arvind
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Unit
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2021-05-20 11:08 Tx date 2019-08-07 |
$GUD
Knight Therapeutics Inc. |
Utchanah, Arvind
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Unit
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2021-05-20 11:07 Tx date 2021-05-18 |
$GUD
Knight Therapeutics Inc. |
Utchanah, Arvind
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+24,940 vol |
||
| Filed 2021-05-20 11:07 Tx date 2021-05-18 |
$GUD
Knight Therapeutics Inc. |
Utchanah, Arvind
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+24,940 vol |
248,489 | |
| Filed 2021-04-06 08:44 Tx date 2021-03-15 |
$GUD
Knight Therapeutics Inc. |
Utchanah, Arvind
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$3,800
+728 vol $5.22 each |
7,705 | |
| Filed 2020-12-21 19:01 Tx date 2020-12-15 |
$GUD
Knight Therapeutics Inc. |
Utchanah, Arvind
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$3,153
+595 vol $5.30 each |
6,977 | |
| Filed 2020-09-28 16:45 Tx date 2020-09-15 |
$GUD
Knight Therapeutics Inc. |
Utchanah, Arvind
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$3,424
+567 vol $6.04 each |
6,382 |